Neurizon Therapeutics Limited (ASX:NUZ) Reports New Preclinical Data Supporting ALS Treatment
Neurizon Therapeutics (ASX:NUZ) announces positive preclinical results for NUZ-001, highlighting its potential as a transformative ALS therapy.
Galan Lithium Limited (ASX:GLN) Secures A$20 Million Placement with Clean Elements Fund
Galan Lithium Limited (ASX:GLN) secures a A$20 million placement with Clean Elements Fund to complete Phase 1 of its Hombre Muerto West project.
Cygnus Metals Limited (ASX:CY5) Raises $18.3M to Accelerate Resource Growth
Cygnus Metals Limited (ASX:CY5) raises A$18.3M through a share placement to accelerate resource growth and mining studies.
Streamplay Studio Limited (ASX:SP8) Announces Strong Game Launch Metrics and Future Releases
Streamplay Studio (ASX:SP8) reports strong metrics for recent game launches and outlines plans for future releases across multiple platforms.
Race Oncology Ltd (ASX:RAC) Initiates Phase 1 RC220 + Doxorubicin Trial
Race Oncology (ASX:RAC) safely doses first patient in Phase 1 RC220 + Doxorubicin trial, advancing solid tumour treatments.
Mayne Pharma Group Limited (ASX:MYX) Approves Acquisition by Cosette Pharmaceuticals
Mayne Pharma Group Limited (ASX:MYX) shareholders approve Cosette Pharmaceuticals’ acquisition with 99.06% voting in favor.
Codeifai Limited (ASX:CDE) Acquires Trust Codes to Enhance AI QR Solutions
Codeifai (ASX:CDE) acquires Trust Codes to enhance its AI-driven QR code traceability and expand global market presence.
Element 25 (ASX:E25) Secures $50M Finance for Butcherbird Expansion
Element 25 (ASX:E25) secures AU$50M from NAIF to expand its Butcherbird Manganese Project, enhancing its role in the global battery supply chain.
4DMedical Limited (ASX:4DX) Expands Contract with Stanford University
4DMedical Limited (ASX:4DX) expands its contract with Stanford University, including new imaging technologies ahead of FDA clearance.
Harvest Technology Group (ASX:HTG) Advances Profit Pathway One Year Early
Harvest Technology Group (ASX:HTG) is accelerating its Pathway to Profit strategy, achieving a significant reduction in EBITDA loss and launching the NEON Edge AI solution.